In PLoS One this week, scientists used comparative gene expression analysis to determine a possible signature that could serve as a biomarker to distinguish between patients with stable idiopathic pulmonary fibrosis and those where the disease progressed rapidly.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.